Feature | February 19, 2014

Experimental Wireless Messaging Technology Remotely Monitors Patient Heart Conditions

LAPTOP-HF Telecardiology Remote Patient Monitoring ICM EP Lab Heart Failure ECG

February 19, 2014 — A new treatment option for heart disease is being tested at The University of Kansas Hospital that could be significant in telemedicine. Using an implantable monitoring device, the patient can hold a smartphone-type device to the chest and the device will relay info wirelessly from the heart implant to the doctors at the hospital. It allows doctors the ability to better personalize treatment for heart failure patients while giving those patients more control of their chronic condition.

The clinical trial is called LAPTOP-HF (Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy.) Dhanunjaya Lakkireddy, an electrophysiologist at The University of Kansas Hospital, said the LAPTOP-HF monitor can give heart patients and their doctors critical information immediately. 

"Before this device, any of these measurements had to be taken here in our office. Now with this technology, we can obtain the information from the patient's home," Lakkireddy said. "It's especially helpful for patients who live a long way from us. We can constantly monitor their condition and give them medication changes any time, rather than waiting for a scheduled appointment."

That's a huge benefit for Larry Stewart, who lives nearly two hours south of the hospital in Bronson, Kan. Before enrolling in the trial, Stewart and his wife had to make the journey to see Lakkireddy about every six weeks for congestive heart failure and atrial fibrillation.

Now, after having the device (which looks like a pacemaker) surgically implanted in his chest, all Stewart has to do each day is hold the small monitor (the size of a smartphone) up to his chest and the readings are electronically sent back to the doctor's office for instant analysis. 

"It makes me feel better that there's something there that's measuring and keeping an eye on my heart," Stewart said. 

It also means only making the trip to the doctor's office every three months, while still being monitored regularly, which is especially helpful during winter months when road conditions can be dangerous. 

St. Jude Medical developed the monitor. The University of Kansas Hospital is among the 75 sites in the United States chosen to evaluate the safety and effectiveness of the device.

For more information: www.kumed.com

Related Content

Acutus Medical, AcQMap EP Imaging and Mapping System, CE Mark
News | EP Mapping and Imaging Systems| May 04, 2016
Acutus Medical announced CE Mark approval for its AcQMap High Resolution Imaging and Mapping System and AcQMap Catheter...
Biotronik, FDA, MR Conditional CRT devices, Iperia HF-T, defibrillator, ProMRI
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 03, 2016
Biotronik announced U.S. Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac resynchronization...
American Society of Echocardiography, ASE guideline, left ventricular diastolic function, LV, heart failure, JASE
News | Cardiovascular Ultrasound| May 03, 2016
May 3, 2016 — Good news for clinicians and their patients: the evaluation of left ventricular (LV) diastolic function
CardioMEMS, implantable hemodynamic monitor, Fontan anatomy, Nationwide Children's Hospital, Wexner Medical Center
News | Implantable Cardiac Monitor (ICM)| May 02, 2016
In a recent case series, clinicians from The Heart Center at Nationwide Children’s Hospital and The Ohio State...
AtriCure, AtriClip PRO2 LAA Exclusion System, left atrial appendage, FDA clearance
Technology | Left Atrial Appendage (LAA) Occluders| April 29, 2016
April 29, 2016 — AtriCure Inc. announced U.S.
microtubules, heartbeat mechanics, Perelman School of Medicine study

Microtubules in a cardiomyocyte at rest (top) and when compressed. Image courtesy of the lab of Ben Prosser, Ph.D., Perelman School of Medicine, University of Pennsylvania

News | EP Lab| April 29, 2016
Using new high-resolution microscopy, researchers have found that molecular struts called microtubules (MT) interact...
Boston Scientific, FDA, ImageReady MR-Conditional Pacing System
Technology | EP Lab| April 28, 2016
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for...
breast cancer, herceptin chemotherapy drug, heart damage, monitoring, Journal of Clinical Oncology study
News | Cardiac Diagnostics| April 28, 2016
April 28, 2016 — Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored
Feature | Business| April 28, 2016 | Dave Fornell
 
coronary CT angiography, CCTA, SCOT-HEART trial substudy, SCCT
News | Computed Tomography (CT)| April 26, 2016
The results of a secondary analysis of the SCOT-HEART trial show that coronary computed tomography angiography (CCTA)...
Overlay Init